8-K
filed September 26, 2024, 7:59 PM ET
ticker PHGE
CIK 0001739174
other material
confidence high
sentiment neutral
materiality 0.40
BiomX provides pipeline update: BX004 Ph2b results in Q3 2025, BX211 Ph2 results in Q1 2025
BiomX Inc.
- BX004 for CF: Phase 2b topline results expected Q3 2025 (60 patients, 2:1 randomized).
- BX211 for DFO: Phase 2 topline results expected Q1 2025 (week 26) and Q1 2026 (week 52).
- Cash and cash equivalents $32.7M as of June 30, 2024.
- Presentation highlights: 14.3% of BX004 patients converted to PsA-negative sputum in Ph1b/2a Part 2.
- Peer phage therapy momentum cited: >100 compassionate use cases with 77% clinical improvement.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001213900-24-081948
- form_type
- 8-K
- ticker
- PHGE
- cik
- 0001739174
- company_name
- BiomX Inc.
- filed_at
- 2024-09-26T23:59:59+00:00
- discovered_at
- 2026-05-14T18:03:14.371232+00:00
- generated_at
- 2026-05-31T01:37:45.765413+00:00
- sec_items
- ["7.01", "9.01"]
- event_type
- other_material
- sentiment
- neutral
- materiality_score
- 0.4
- calibrated_materiality_score
- 0.4
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001213900-24-081948
- json_url
- https://secwatch.observer/filing/0001213900-24-081948.json
- markdown_url
- https://secwatch.observer/filing/0001213900-24-081948.md
- text_url
- https://secwatch.observer/filing/0001213900-24-081948.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1739174/000121390024081948/0001213900-24-081948-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1739174/000121390024081948/ea0215609-8k_biomx.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
SMC
Summit Midstream Corporation announces inaugural $35 million stock repurchase program
Summit Midstream Corp
June 1, 2026, 4:31 PM ET
other_material
Items 7.01, 9.01
same SEC item: 7.01, 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
RMR
RMR highlights $37B AUM, 40%+ EBITDA margins, and $120M liquidity in investor presentation
RMR GROUP INC.
June 1, 2026, 4:11 PM ET
other_material
Items 7.01, 9.01
same SEC item: 7.01, 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
QBTS
D-Wave Quantum holds first Investor Day; presents on technology and financial overview
D-Wave Quantum Inc.
June 1, 2026, 12:50 PM ET
other_material
Items 7.01, 9.01
same SEC item: 7.01, 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
ATRO
Astronics announces 20% Class B stock distribution to all shareholders
ASTRONICS CORP
June 1, 2026, 9:05 AM ET
other_material
Items 7.01, 9.01
same SEC item: 7.01, 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
CRM
Salesforce shareholders approve 34M share equity plan increase, extend term to 2036, all directors re-elected
Salesforce, Inc.
June 1, 2026, 4:43 PM ET
other_material
Items 5.07, 5.02, 9.01
same SEC item: 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
EMYB
Embassy Bancorp expands stock repurchase program by additional $5M
Embassy Bancorp, Inc.
June 1, 2026, 4:37 PM ET
other_material
Items 8.01, 9.01
same SEC item: 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
MXL
MaxLinear dismisses Grant Thornton, appoints KPMG as auditor for FY2026
MAXLINEAR, INC
June 1, 2026, 4:35 PM ET
other_material
Items 4.01, 9.01
same SEC item: 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
BRANDYWINE OPERATING PARTNERSHIP, L.P.
Brandywine extends revolver maturity to Dec 2026; shareholders OK 5M share increase for LTIP
BRANDYWINE OPERATING PARTNERSHIP, L.P.
June 1, 2026, 4:30 PM ET
other_material
Items 1.01, 2.03, 5.02, 5.07, 9.01
same SEC item: 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.